HP
36
2
BWA
55
-5
PLD
58
2
MAT
30
-2
RRC
70
12
PH
60
-2
TXT
70
-2
CVS
52
2
JCI
51
-3
AMGN
39
-5
VIX
38
-3
PYPL
32
3
SRE
68
2
EXR
44
4
NAVI
40
2
WDC
66
-2
CINF
58
3
MO
45
-2
VTR
63
6
ADBE
44
3
HP
36
2
BWA
55
-5
PLD
58
2
MAT
30
-2
RRC
70
12
PH
60
-2
TXT
70
-2
CVS
52
2
JCI
51
-3
AMGN
39
-5
VIX
38
-3
PYPL
32
3
SRE
68
2
EXR
44
4
NAVI
40
2
WDC
66
-2
CINF
58
3
MO
45
-2
VTR
63
6
ADBE
44
3
Financhill
Back

First Trust Intermediate Duration Preferred & Income Fund Vs. Celldex Therapeutics, Inc. Industry Stock Comparison

Sell
33

FPF
First Trust Intermediate Duration Preferred & Income Fund

Last Price:
$17.75
Seasonality Move:
6.77%
Sell
48

CLDX
Celldex Therapeutics, Inc.

Last Price:
$31.05
Seasonality Move:
20.93%
Sell
33
First Trust Intermediate Duration Preferred & Income Fund (FPF) is a Sell

Is First Trust Intermediate Duration Preferred & Income Fund a Buy, Sell or Hold?

  • The current First Trust Intermediate Duration Preferred & Income Fund [FPF] share price is $17.74. The Score for FPF is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • FPF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Celldex Therapeutics, Inc. (CLDX) is a Sell

Is Celldex Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Celldex Therapeutics, Inc. [CLDX] share price is $31.05. The Score for CLDX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CLDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FPF Stock Price Chart

What is First Trust Intermediate Duration Preferred & Income Fund's stock price today?

CLDX Stock Price Chart

What is Celldex Therapeutics, Inc.'s stock price today?

  • The Celldex Therapeutics, Inc. share price today is $31.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing buying pressure, which is a positive indicator for future bullish movement.

FPF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 41.02 Sell
Chaikin Money Flow: 38314 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.65 - 18.61) Sell
Bollinger Bands (100): (18.19 - 19.03) Sell

CLDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.9 Buy
Relative Strength Index (14 RSI): 55.97 Buy
Chaikin Money Flow: 3988094 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.43 - 31.31) Buy
Bollinger Bands (100): (24.48 - 29.54) Buy

FPF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.63 Buy
20-day SMA: 17.96 Sell
50-day SMA: 18.57 Sell
200-day SMA: 18.78 Sell
8-day EMA: 17.67 Buy
20-day EMA: 17.96 Sell
50-day EMA: 18.35 Sell
200-day EMA: 18.6 Sell

CLDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.05 Buy
20-day SMA: 30.57 Buy
50-day SMA: 27.66 Buy
200-day SMA: 25.4 Buy
8-day EMA: 30.94 Buy
20-day EMA: 30.26 Buy
50-day EMA: 28.67 Buy
200-day EMA: 26.26 Buy

First Trust Intermediate Duration Preferred & Income Fund Earnings Growth & FPF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Celldex Therapeutics, Inc. Earnings Growth & CLDX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.20 per share, a decrease this year of $1.19 per share, and an increase next year of $0.04 per share.

First Trust Intermediate Duration Preferred & Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Celldex Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):